Regenerative Medical Solutions, Inc. (RMS) provides consulting services in conjunction with ProgenMix™, ourmedia formulation, to allow its customers to grow pancreatic progenitor cells more efficiently and effectively than their current capabilities. Our protocol has been compared in the laboratory head to head with the current gold standard and results in greater pancreatic gene expression. Furthermore, our differentiation protocol can generate up to 90% pancreatic progenitor cells which compares favorably with other published protocols (20-80%). Our products are rigorously tested and have undergone multiple optimization studies to achieve the highest quality culture media. Our media allows scientists and researchers the ability to cultivate pancreatic progenitor cells more efficiently and effectively, while yielding consistent and robust results.
- ProgenMix™ Media Formulation
- RMS Personalized Consulting Services